Chinese Hamster Ovaries (CHO) and cell lines
Chinese Hamster Ovaries (CHO) and cell lines Companies (7)
Chinese Hamster Ovaries (CHO) and cell lines News
-
News Novartis and Viatris latest facing lawsuit over HeLa cell misuse
Global pharmaceutical companies Novartis and Viatris are the latest hit with a lawsuit claim pertaining to alleged misuse of the ‘HeLa’ cell line from the estate of woman whose cancerous tissue cells were taken without consent.
-
News ProBioGen and LAVA Therapeutics sign cell line development agreement
The agreement marks the second cell line development collaboration between the two companies
-
News ProBioGen selected for development and large-scale manufacturing services
The Contract Development and Manufacturing Organization (CDMO) and technology provider will use its CHO.RiGHT expression platform for high-titer cell line development. -
News FUJIFILM Irvine Scientific launches BalanCD Gal Supplement for biotherapeutic development
Delivers enhanced galactosylation for improved protein quality, and antibody binding and function.
Chinese Hamster Ovaries (CHO) and cell lines Products (31)
-
Product Biologics Development Solutions for Companion Animal Therapeutics
Leverages advanced expression technologies, optimised vectors, and flexible bioprocessing platforms to deliver scalable and cost‑efficient solutions tailored to companion animal biologics. Supports from early development to GMP manufacturing, with customisation for veterinary specific requirements.
-
Product Cell Line Development services
Cell line development services, including molecular cloning, CHO cell line development and lead clone selection, upstream bioprocess optimization, Down stream bioprocessing and analytical characterization of the target molecule. In addition to a detailed documentation in line with regulatory requirement...
-
Product Cell Culture Media
JSBio, a prominent brand in Asia, is a leading provider of serum-free cell culture media. Our comprehensive product portfolio covers a wide spectrum of cell lines, with a strong focus on mainstream ones like CHO, 293, insect cells, and BHK .These media are extensively applied across core biopharmaceutical ...
-
Product CHO and HEK stable cell line development
Fast and efficient delivery of high-yielding stable CHO or HEK clones, with a productivity of up to 8 g/L within 8-12 weeks. Your benefit: Success assurance with the best cell line, right from the start. https://excellgene.com/ https://excellgene.com/offerings/cell-line-development/ https://excellgene.com/...
-
Product Specialty Cell Culture Media, Cell Lines and Contract Services for Baculovirus Expression Vector Systems
Expression Systems, now an Advancion company, is dedicated to supplying and servicing the cell culture and bio-industrial markets with innovative cell culture media formulations, as well as cell lines, molecular tools, reagents, and contract services. The company specializes in the baculovirus expression v...
-
Product Biologic drug substance CDMO services
From early development, including mammalian cell line development, cell culture development, and process development, through to pre-clinical production and commercial supply, Patheon by Thermo Fisher Scientific provides CDMO services for protein-based biologic therapeutics. Patheon offers biotech and ...
-
Product A CDMO PARTNER FOR LIFE
FUJIFILM Diosynth Biotechnologies is an industry-leading cGMP Contract Development and Manufacturing Organization (CDMO) supporting the biopharmaceutical industry in the development and production of biologics, vaccines and cell and gene therapies. Our focus is to combine technical leadership in process d...
-
Product Dissolvable Microcarriers
Our Dissolvable Microcarrier delivers significantly higher yields and fits seamlessly into your existing workflow. Start with research-grade product for early-stage development, and transition smoothly to clinical use with the GMP-grade.
• With over 90% cell harvesting efficiency and viability, ou...
-
Product E. Coli Host Cell Proteins
ELISA methods are used to test for the presence of residual host cell proteins left in a drug or therapeutic protein following purification.
-
Product Biomedical and Healthcare Recombinant Protein Solutions
Combines molecular engineering, host cell optimisation, expression system development, and process optimisation to address complex protein structures. The IgMax® platform enables production of pentameric IgM at high expression levels, with near‑complete pentamer assembly and excellent purity after downstre...
-
Product Recombinant Antigen and Vaccine Solutions for Livestock & Poultry
Combines advanced expression technologies with optimised vectors, cell culture processes, and downstream purification for high‑productivity and cost‑efficient manufacturing. Multimerisation and nanoparticle platforms enable the design of defined antigen structures in various multimeric forms, supporting ne...
-
Product Integrated Biosimilar CMC Solutions – from Development to Commercial Manufacturing
End‑to‑end biosimilar development from cell line construction to PPQ and commercial batches. The integrated platform enables a fast development timeline, supports global GMP requirements, and offers competitive cost of goods. Includes DS/DP manufacturing, analytical testing, quality support, and technology...
-
Product Innovative Drug Solutions for Difficult‑to‑Express and Complex Proteins
Integrated development and manufacturing solutions combining molecular engineering, vector optimization, host cell engineering, and customized process development. The platform delivers high titers for mAb production, and DTEasy™ strategies have demonstrated significant yield improvements across various di...
-
Product CHO Prime® Media & Feeds for CHO cell culture
CHO Prime® is a next-generation, GMP-compliant, adaptive media platform designed to maximise productivity while giving you precise control over critical quality attributes, particularly glycosylation. Built for production of biologics and biosimilars, CHO Prime® combines chemically defined, animal componen...
-
Product Ready-to Use CHO cell lines
UGA Biopharma GmbH offers to their clients Ready-to-use Biosimilar Cell Lines. These are in-house developed CHO cell lines stably expressing different blockbuster biosimilar molecules, that are instantly available for in-licensing. The client profits of direct availability of cell lines banks and prompt ac...
-
Product Cell Host Technologies
Outlicensing of superior cell hosts: CHOExpress® & HEKExpress®, cell line generation with best in class transposon technology. Your benefit: In-house state of the art tech revolutionizing your development programs. https://excellgene.com/technologies/
-
Product Bioprocess Development
Integrated upstream and downstream process development for high-yield manufacturing of biologics of desired quality. Your benefit: Cost-effective and scalable bioprocess with robust and reliable tech transfer. https://excellgene.com/offerings/downstream-process-development-dsp/ https://excellgene.com/offer...
-
Product cGMP Cell Bank Manufacturing
cGMP-compliant MCB/WCB preparation of in-house or brought-in CHO-/HEK-based cell lines. Your benefit: Risk-free and fast preparation, release of MCB/WCB. https://excellgene.com/offerings/cgmp-master-cell-banking/
-
Product Biosimilars
Portfolio of high-producing biosimilar cell lines and processes, off-the-shelf and generation of such from scratch. Biosimilarity optimisation of your recombinant cell line. Your benefit: Cost and time-savings, while bringing your product to the market. https://excellgene.com/offerings/biosimilars/
-
Product Chinese Hamster Ovary Host Cell Protein Testing
ELISA methods are used to test for the presence of residual host cell proteins left in a drug or therapeutic protein following purification.
Upcoming Events
-
CPHI South East Asia 2026
QSNCC, Bangkok, Thailand
08 Jul 2026 - 10 Jul 2026 -
CPHI Korea 2026
COEX, Seoul, Korea
25 Aug 2026 - 27 Aug 2026 -
CPHI & PMEC Shenzhen 2026
Shenzhen Convention & Exhibition Center (SZCEC), China
16 Sep 2026 - 18 Sep 2026
